
    
      PMX-60056 is being developed as a rapid and effective reversal agent for use in those
      situations where anticoagulation by heparin, or LMWH must be quickly stopped. Potential uses
      include reversal of anticoagulation induced to prevent clotting during surgical procedures,
      and rescue from cases of inadvertent or unexpected overdose.
    
  